Medical Patent News

RSS

MedImmune statement on MedImmune vs. Genentech Supreme Court decision

MedImmune issued the following statement regarding today's U.S. Supreme Court decision in MedImmune, Inc. vs. Genentech, Inc. et al.

9 Jan 2007

VeriChip awarded U.S. patent for RFID asset tracking system

Applied Digital Solutions, though its subsidiary VeriChip Corporation has announced today that the U.S. Patent and Trademark Office has granted VeriChip Corp. a patent for its portable RFID asset location system.

8 Jan 2007

NanoMed Pharmaceuticals issued new U.S. nanoparticle patent

NanoMed Pharmaceuticals has announced that founders Russell J. Mumper, Ph.D. and Michael Jay, Ph.D. have been issued U.S. Patent 7,153,525 entitled "Microemulsions As Precursors To Solid Nanoparticles."

3 Jan 2007

Cytogen issued new patent covering oral drug delivery agents

Cytogen Corporation has announced that it has been issued United States patent number 7,135,457 covering its oral drug delivery agents - random peptide compositions that bind to gastro-intestinal tract (GIT) transport receptors.

28 Nov 2006

VNUS Medical Technologies announces favorable ruling in patent case

VNUS Medical Technologies, Inc has announced that United States District Judge Maxine M. Chesney of the United States District Court for the Northern District of California issued a Markman order in the litigation brought by VNUS Medical Technologies against Diomed Holdings, Inc. and Diomed, Inc., AngioDynamics, Inc. and Vascular Solutions, Inc. (the "defendants").

23 Nov 2006

SpectraScience files new patent application

SpectraScience has announced that it has filed for a new patent with the United States Patent and Trademark Office.

13 Nov 2006

Pfizer provides opinion on European Lipitor patent

Pfizer has said that the European Patent Office (EPO) has issued an opinion upholding, in its entirety, the company's calcium salt patent covering Lipitor.

30 Oct 2006

Nanogen announces new patents for inventions related to diabetes and Alzheimer's disease biomarkers

Nanogen has announced that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimer's disease biomarkers.

30 Oct 2006

Spanish patent victory favoring Ranbaxy on Atorvastatin unaffected

Ranbaxy Laboratories Limited said today that recently, in two separate rulings, the Spanish courts (the Mercantile Court of Barcelona, No. 2) found Spanish patent ES 2,167,306 (counterpart of Pfizer's EP 409 281) to be invalid for lack of novelty.

30 Oct 2006

Austrian patent office rules in Pfizer's Favor for Lipitor patent

Pfizer has announced that the Austrian Patent Office has ruled that a claim in the company's basic patent covering the use of atorvastatin, the active ingredient in Lipitor, would be infringed by generic manufacturer Ranbaxy.

19 Oct 2006

Victhom files provisional sleep apnea patent application

Victhom Human Bionics announced that, after a series of pilot animal studies on potential medical indications of its Closed Loop System (the CLS Neuromodulator).

19 Oct 2006

Researchers patent novel method for measuring blood pressure in the heart

Researchers at Virginia Commonwealth University Medical Center have developed and patented a new, noninvasive means of measuring blood pressure inside the heart.

21 Sep 2006

Combating generics: pharmaceutical brand defense for 2007

Court cases regarding patent infringement effectively slow generics in coming to market, however US lawmakers and FDA continue to make it easier for generic drugs to gain approval (Cutting Edge Information).

21 Sep 2006

Ranbaxy invalidates Pfizer's 281 patent in Holland

Ranbaxy Laboratories Limited (Ranbaxy) has announced that The District Court of The Hague has handed down a decision in Ranbaxy's case against (Pfizer) Warner-Lambert over the cholesterol-lowering drug, atorvastatin, which is marketed by Pfizer as Lipitor(R).

14 Sep 2006

Dutch court upholds Lipitor patent

Pfizer said today that the District Court of The Hague in the Netherlands has ruled that the basic patent covering atorvastatin - the active ingredient in Lipitor - would be infringed by a competitor product from generics manufacturer Ranbaxy.

13 Sep 2006

Bavarian Nordic's modified Vaccinia Ankara patents infringed

The Administrative Law Judge at the U.S. International Trade Commission (ITC) issued his Initial Determination concluding that Acambis plc's smallpox vaccine product (MVA3000) infringes two of Bavarian Nordic's patents on Modified Vaccinia Ankara (MVA) and furthermore that Bavarian Nordic's patents are enforceable.

11 Sep 2006